Inventor
O'NEIL KARYN
US38 patents
⚠️ This page may combine multiple inventors who share the name “O'NEIL KARYN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN BIOTECH INC
19 patentsUS10196446B2Feb 5, 2019
Cysteine engineered fibronectin type III domain binding molecules
JANSSEN BIOTECH INC16 citations92
US9695228B2Jul 4, 2017
EGFR and c-Met fibronectin type III domain binding molecules
JANSSEN BIOTECH INC15 citations90
US10040842B2Aug 7, 2018
Fibronectin type III domain based scaffold compositions, methods and uses
JANSSEN BIOTECH INC6 citations84
US9725497B2Aug 8, 2017
EGFR and C-Met fibronectin type III domain binding molecules
JANSSEN BIOTECH INC5 citations83
US8883447B2Nov 11, 2014
Anti-GLP-1R antibodies and their uses
JANSSEN BIOTECH INC5 citations83
US10925932B2Feb 23, 2021
Serum albumin-binding fibronectin type III domains
JANSSEN BIOTECH INC8 citations82
US10662235B2May 26, 2020
Cysteine engineered fibronectin type III domain binding molecules
JANSSEN BIOTECH INC4 citations72
US11833190B2Dec 5, 2023
Serum albumin-binding fibronectin type III domains
JANSSEN BIOTECH INC1 citations71
US10844122B2Nov 24, 2020
Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof
JANSSEN BIOTECH INC4 citations68
US12291797B2May 6, 2025
Fibronectin type III domain based scaffold compositions, methods and uses
JANSSEN BIOTECH INC0 citations62
US11479880B2Oct 25, 2022
Fibronectin type III domain based scaffold compositions, methods and uses
JANSSEN BIOTECH INC0 citations62
US12304939B2May 20, 2025
EGFR and C-met fibronectin type III domain binding molecules
JANSSEN BIOTECH INC0 citations61
US10954284B2Mar 23, 2021
EGFR and c-Met fibronectin type III domain binding molecules
JANSSEN BIOTECH INC0 citations61
US12054534B2Aug 6, 2024
Prostate specific membrane antigen binding fibronectin type iii domains
JANSSEN BIOTECH INC0 citations60
US11702475B2Jul 18, 2023
Cysteine engineered fibronectin type III domain binding molecules
JANSSEN BIOTECH INC0 citations60
US11072663B2Jul 27, 2021
Cysteine engineered fibronectin type III domain binding molecules
JANSSEN BIOTECH INC0 citations60
US10654913B2May 19, 2020
Fibronectin type III domain based scaffold compositions, methods and uses
JANSSEN BIOTECH INC0 citations52
US10844111B2Nov 24, 2020
Prostate specific membrane antigen binding fibronectin type III domains
JANSSEN BIOTECH INC0 citations49
US9206244B2Dec 8, 2015
IL4/IL13 binding repeat proteins and uses
JANSSEN BIOTECH INC1 citations49
Aro Biotherapeutics Company
5 patentsUS11628222B2Apr 18, 2023
CD71 binding fibronectin type III domains
Aro Biotherapeutics Company5 citations82
US11781138B2Oct 10, 2023
FN3 domain-siRNA conjugates and uses thereof
Aro Biotherapeutics Company4 citations71
US12589159B2Mar 31, 2026
CD71 binding fibronectin type III domains
Aro Biotherapeutics Company0 citations59
US12491255B2Dec 9, 2025
EPCAM binding fibronectin type III domains
Aro Biotherapeutics Company0 citations59
US12351619B2Jul 8, 2025
Serum albumin-binding fibronectin type III domains and uses thereof
Aro Biotherapeutics Company0 citations59
JACOBS STEVEN
4 patentsUS8278419B2Oct 2, 2012
Fibronectin type III domain based scaffold compositions, methods and uses
JACOBS STEVEN108 citations98
US8293482B2Oct 23, 2012
Fibronectin type III domain based scaffold compositions, methods and uses
JACOBS STEVEN65 citations97
US8722618B2May 13, 2014
IL4/IL13 binding repeat proteins and uses
JACOBS STEVEN37 citations91
US8415291B2Apr 9, 2013
Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and uses
JACOBS STEVEN0 citations52
CENTOCOR INC
3 patentsUS7910101B2Mar 22, 2011
Melanocortin receptor binding mimetibodies, compositions, methods and uses
CENTOCOR INC11 citations83
US7514539B2Apr 7, 2009
Epitope directed selection of antibodies to murine tissue factor
CENTOCOR INC2 citations63
US7790405B2Sep 7, 2010
Solution phase biopanning method using engineered decoy proteins
CENTOCOR INC0 citations52